Mobile

Efficacy and safety of olaparib in relapsed and refractory chronic lymphocytic leukaemia patients with an 11q deletion or ATM mutation and relapsed/refractory patients with T-prolymphocytic leukaemia ...

Mise à jour : Il y a 4 ans
Référence : ISRCTN34386131

Efficacy and safety of olaparib in relapsed and refractory chronic lymphocytic leukaemia patients with an 11q deletion or ATM mutation and relapsed/refractory patients with T-prolymphocytic leukaemia and mantle cell lymphoma

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

http://cancerhelp.cancerresearchuk.org/trials/a-trial-looking-new-drug-olaparib-leukaemia-mantle-cell-lymphoma-that-has-stopped-responding-treatment-piclle

Critère d'inclusion

  • Chronic Lymphocytic Leukaemia

Liens